145 related articles for article (PubMed ID: 16322270)
1. Antibody microarray profiling reveals individual and combined serum proteins associated with pancreatic cancer.
Orchekowski R; Hamelinck D; Li L; Gliwa E; vanBrocklin M; Marrero JA; Vande Woude GF; Feng Z; Brand R; Haab BB
Cancer Res; 2005 Dec; 65(23):11193-202. PubMed ID: 16322270
[TBL] [Abstract][Full Text] [Related]
2. Distinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis.
Gao WM; Kuick R; Orchekowski RP; Misek DE; Qiu J; Greenberg AK; Rom WN; Brenner DE; Omenn GS; Haab BB; Hanash SM
BMC Cancer; 2005 Aug; 5():110. PubMed ID: 16117833
[TBL] [Abstract][Full Text] [Related]
3. Detection of pancreatic cancer using antibody microarray-based serum protein profiling.
Ingvarsson J; Wingren C; Carlsson A; Ellmark P; Wahren B; Engström G; Harmenberg U; Krogh M; Peterson C; Borrebaeck CA
Proteomics; 2008 Jun; 8(11):2211-9. PubMed ID: 18528842
[TBL] [Abstract][Full Text] [Related]
4. Plasma protein profiling for diagnosis of pancreatic cancer reveals the presence of host response proteins.
Koomen JM; Shih LN; Coombes KR; Li D; Xiao LC; Fidler IJ; Abbruzzese JL; Kobayashi R
Clin Cancer Res; 2005 Feb; 11(3):1110-8. PubMed ID: 15709178
[TBL] [Abstract][Full Text] [Related]
5. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J
Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732
[TBL] [Abstract][Full Text] [Related]
6. Protein profiling in human sera for identification of potential lung cancer biomarkers using antibody microarray.
Han MK; Oh YH; Kang J; Kim YP; Seo S; Kim J; Park K; Kim HS
Proteomics; 2009 Dec; 9(24):5544-52. PubMed ID: 20017155
[TBL] [Abstract][Full Text] [Related]
7. Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling.
Ehmann M; Felix K; Hartmann D; Schnölzer M; Nees M; Vorderwülbecke S; Bogumil R; Büchler MW; Friess H
Pancreas; 2007 Mar; 34(2):205-14. PubMed ID: 17312459
[TBL] [Abstract][Full Text] [Related]
8. Antibody microarray profiling of human prostate cancer sera: antibody screening and identification of potential biomarkers.
Miller JC; Zhou H; Kwekel J; Cavallo R; Burke J; Butler EB; Teh BS; Haab BB
Proteomics; 2003 Jan; 3(1):56-63. PubMed ID: 12548634
[TBL] [Abstract][Full Text] [Related]
9. Antibody array profiling reveals serum TSP-1 as a marker to distinguish benign from malignant prostatic disease.
Shafer MW; Mangold L; Partin AW; Haab BB
Prostate; 2007 Feb; 67(3):255-67. PubMed ID: 17192876
[TBL] [Abstract][Full Text] [Related]
10. Spiking of serum specimens with exogenous reporter peptides for mass spectrometry based protease profiling as diagnostic tool.
Findeisen P; Peccerella T; Post S; Wenz F; Neumaier M
Rapid Commun Mass Spectrom; 2008 Apr; 22(8):1223-9. PubMed ID: 18348224
[TBL] [Abstract][Full Text] [Related]
11. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
[TBL] [Abstract][Full Text] [Related]
12. [Application of serum protein profiling in diagnosis, prognosis and evaluation of curative effect of pancreatic adenocarcinoma].
Guo JH; Wang WJ; Liao P; Zhang CY; Jin DY; Lou WH; Zhang SC
Zhonghua Zhong Liu Za Zhi; 2010 Jan; 32(1):33-6. PubMed ID: 20211064
[TBL] [Abstract][Full Text] [Related]
13. CEACAM1, a novel serum biomarker for pancreatic cancer.
Simeone DM; Ji B; Banerjee M; Arumugam T; Li D; Anderson MA; Bamberger AM; Greenson J; Brand RE; Ramachandran V; Logsdon CD
Pancreas; 2007 May; 34(4):436-43. PubMed ID: 17446843
[TBL] [Abstract][Full Text] [Related]
14. Serum proteome profiling of metastatic breast cancer using recombinant antibody microarrays.
Carlsson A; Wingren C; Ingvarsson J; Ellmark P; Baldertorp B; Fernö M; Olsson H; Borrebaeck CA
Eur J Cancer; 2008 Feb; 44(3):472-80. PubMed ID: 18171612
[TBL] [Abstract][Full Text] [Related]
15. Optimized normalization for antibody microarrays and application to serum-protein profiling.
Hamelinck D; Zhou H; Li L; Verweij C; Dillon D; Feng Z; Costa J; Haab BB
Mol Cell Proteomics; 2005 Jun; 4(6):773-84. PubMed ID: 15793073
[TBL] [Abstract][Full Text] [Related]
16. Proteomic classification of pancreatic adenocarcinoma tissue using protein chip technology.
Scarlett CJ; Smith RC; Saxby A; Nielsen A; Samra JS; Wilson SR; Baxter RC
Gastroenterology; 2006 May; 130(6):1670-8. PubMed ID: 16697731
[TBL] [Abstract][Full Text] [Related]
17. Multiplexed analysis of glycan variation on native proteins captured by antibody microarrays.
Chen S; LaRoche T; Hamelinck D; Bergsma D; Brenner D; Simeone D; Brand RE; Haab BB
Nat Methods; 2007 May; 4(5):437-44. PubMed ID: 17417647
[TBL] [Abstract][Full Text] [Related]
18. [A predictive model for pancreatic cancer using serum protein footprint map].
Long J; Di Y; Jin C; Yu XJ; Liu WW; Chen YM; Fu DL; Ni QX
Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(22):1533-6. PubMed ID: 18956633
[TBL] [Abstract][Full Text] [Related]
19. [Preliminary study of serum proteome biomarkers of hypopharyngeal squamous cell carcinoma].
Cheng L; Zhou L; Tao L; Xiang CQ; Jia XD; Lu Y; Liao P
Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(21):1484-8. PubMed ID: 16842702
[TBL] [Abstract][Full Text] [Related]
20. Analysis of signaling pathways in 90 cancer cell lines by protein lysate array.
Mendes KN; Nicorici D; Cogdell D; Tabus I; Yli-Harja O; Guerra R; Hamilton SR; Zhang W
J Proteome Res; 2007 Jul; 6(7):2753-67. PubMed ID: 17564428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
